Summary

The Global Small Animal Imaging (In-Vivo) Market is valued at approximately USD 2.73 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 9.10% over the forecast period 2024-2032. Small Animal Imaging (In-Vivo) involves the use of sophisticated imaging techniques to visualize and study live small animals, such as rodents, in their natural, living state. This approach enables researchers to track physiological and biochemical processes in real-time without sacrificing the animals. By employing various imaging modalities—such as MRI, PET, CT, and optical imaging—scientists can gain valuable insights into disease progression, treatment efficacy, and biological mechanisms. This non-invasive method is essential for advancing preclinical research and drug development, offering a detailed view of the effects of medical interventions and understanding complex biological systems.

The market's growth is driven by the increasing number of pre-clinical research studies, rising investments by Contract Research Organizations (CROs) in research activities, and the growing application of multi-functional pre-clinical imaging. Additionally, technological advancements, such as high-resolution multimodality MRI, are positively impacting the market. However, stringent regulatory impositions and inadequate reimbursement scenarios pose challenges to the market growth. Nevertheless, the commercialization of cost-efficient devices is expected to ease these restraints and fuel market growth, especially across developing regions.

The key regions considered in the study include Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa. North America dominates the market due to the adoption of advanced technologies, healthcare awareness, and favorable reimbursement policie, attributed to heavy investments and the affordability of advanced small animal in-vivo imaging devices, such as micro-Photoacoustic tomography (Micro-PAT), in pre-clinical research. On the other hand, the Asia-Pacific market is projected to grow at a over the forecast period, driven by the untapped market potential and opportunities for small animal imaging device manufacturers.

Major market players included in this report are:
FUJIFILM Holdings Corporation
Aspect Imaging Ltd.
Miltenyi Biotech GmbH
Thermo Fisher Scientific
Life Technologies Corporation
PerkinElmer, Inc.
Mediso Medical Imaging Systems
Promega Corporation
Siemens AG
Bruker Corporation
Agilent Technologies, Inc.
MR Solutions Ltd.
Biospace Lab
NORDIC BIOSCIENCE
Sofie Biosciences

The detailed segments and sub-segment of the market are explained below:
By Technology:
Micro Magnetic Resonance Imaging
Optical Imaging
Nuclear Imaging
Other Imaging Modalities

By Application:
Monitoring Drug Treatment Response
Biodistribution Studies
Cancer Cell Detection
Biomarkers
Longitudinal Studies
Epigenetics

By Region:
North America
U.S.
Canada

Germany
France
UK
Spain
Italy
Rest of Europe

Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific

Latin America
Brazil
Mexico
Rest of Latin America

Middle East and Africa
Saudi Arabia
South Africa
Rest of Middle East and Africa

Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

ページTOPに戻る

Table of Contents

Chapter 1. Global Small Animal Imaging (In-Vivo) Market Executive Summary
1.1. Global Small Animal Imaging (In-Vivo) Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Technology
1.3.2. By Application
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Small Animal Imaging (In-Vivo) Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Small Animal Imaging (In-Vivo) Market Dynamics
3.1. Market Drivers
3.1.1. Rising Number of Pre-Clinical Research Studies
3.1.2. Increasing Investments by CROs
3.1.3. Growing Application of Multi-Functional Pre-Clinical Imaging
3.2. Market Challenges
3.2.1. Stringent Regulatory Impositions
3.2.2. Inadequate Reimbursement Scenario
3.3. Market Opportunities
3.3.1. Commercialization of Cost-Efficient Devices

Chapter 4. Global Small Animal Imaging (In-Vivo) Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Small Animal Imaging (In-Vivo) Market Size & Forecasts by Technology 2022-2032
5.1. Segment Dashboard
5.2. Global Small Animal Imaging (In-Vivo) Market: Technology Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Micro Magnetic Resonance Imaging
5.2.2. Optical Imaging
5.2.3. Bioluminescence Imaging
5.2.4. Cerenkov Luminescence Imaging
5.2.5. Fluorescence Imaging
5.2.6. Nuclear Imaging
5.2.7. Micro Positron Emission Tomography (Micro PET)
5.2.8. Micro Single Photon Emission Computerized Tomography (Micro SPECT)
5.2.9. Other Imaging Modalities
5.2.10. Micro Computerized Tomography Imaging
5.2.11. Micro Ultrasound Imaging

Chapter 6. Global Small Animal Imaging (In-Vivo) Market Size & Forecasts by Application 2022-2032
6.1. Segment Dashboard
6.2. Global Small Animal Imaging (In-Vivo) Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Monitoring Drug Treatment Response
6.2.2. Biodistribution Studies
6.2.3. Cancer Cell Detection
6.2.4. Biomarkers
6.2.5. Longitudinal Studies
6.2.6. Epigenetics

Chapter 7. Global Small Animal Imaging (In-Vivo) Market Size & Forecasts by Region 2022-2032
7.1. North America Small Animal Imaging (In-Vivo) Market
7.1.1. U.S. Small Animal Imaging (In-Vivo) Market
7.1.1.1. Technology breakdown size & forecasts, 2022-2032
7.1.1.2. Application breakdown size & forecasts, 2022-2032
7.1.2. Canada Small Animal Imaging (In-Vivo) Market
7.1.2.1. Technology breakdown size & forecasts, 2022-2032
7.1.2.2. Application breakdown size & forecasts, 2022-2032
7.2. Europe Small Animal Imaging (In-Vivo) Market
7.2.1. UK Small Animal Imaging (In-Vivo) Market
7.2.2. Germany Small Animal Imaging (In-Vivo) Market
7.2.3. France Small Animal Imaging (In-Vivo) Market
7.2.4. Spain Small Animal Imaging (In-Vivo) Market
7.2.5. Italy Small Animal Imaging (In-Vivo) Market
7.2.6. Rest of Europe Small Animal Imaging (In-Vivo) Market
7.3. Asia-Pacific Small Animal Imaging (In-Vivo) Market
7.3.1. China Small Animal Imaging (In-Vivo) Market
7.3.2. Japan Small Animal Imaging (In-Vivo) Market
7.3.3. India Small Animal Imaging (In-Vivo) Market
7.3.4. South Korea Small Animal Imaging (In-Vivo) Market
7.3.5. Australia Small Animal Imaging (In-Vivo) Market
7.3.6. Rest of Asia Pacific Small Animal Imaging (In-Vivo) Market
7.4. Latin America Small Animal Imaging (In-Vivo) Market
7.4.1. Brazil Small Animal Imaging (In-Vivo) Market
7.4.2. Mexico Small Animal Imaging (In-Vivo) Market
7.4.3. Rest of Latin America Small Animal Imaging (In-Vivo) Market
7.5. Middle East & Africa Small Animal Imaging (In-Vivo) Market
7.5.1. Saudi Arabia Small Animal Imaging (In-Vivo) Market
7.5.2. South Africa Small Animal Imaging (In-Vivo) Market
7.5.3. Rest of Middle East & Africa Small Animal Imaging (In-Vivo) Market

Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. FUJIFILM Holdings Corporation
8.1.2. Aspect Imaging Ltd.
8.1.3. Miltenyi Biotech GmbH
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. FUJIFILM Holdings Corporation
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. Aspect Imaging Ltd.
8.3.3. Miltenyi Biotech GmbH
8.3.4. Thermo Fisher Scientific
8.3.5. Life Technologies Corporation
8.3.6. PerkinElmer, Inc.
8.3.7. Mediso Medical Imaging Systems
8.3.8. Promega Corporation
8.3.9. Siemens AG
8.3.10. Bruker Corporation
8.3.11. Agilent Technologies, Inc.
8.3.12. MR Solutions Ltd.
8.3.13. Biospace Lab
8.3.14. NORDIC BIOSCIENCE
8.3.15. Sofie Biosciences

Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes